NEW YORK (GenomeWeb News) — Sequenom will sell $20 million worth of its common stock to new and existing institutional investors, the company said today.
 
The company said it plans to sell 6.7 million shares for $3 apiece, a 1-cent premium over yesterday’s closing price of $2.99. Sequenom said it plans to close the sale by Friday.  
 
After deductions for expenses, Sequenom said it expects the sale to net around $18.4 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.